A RANDOMIZED CONTROLLED STUDY FOR LEVOFLOXACIN-BASED QUADRUPLE THERAPY IN HELICOBACTER PYLORI ERADICATION

被引：0
|
作者：
Yingyongthawat, Worapoth
Pulsombat, Akharawit
机构：
来源：
GASTROENTEROLOGY | 2019年 / 156卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Su1299
引用
收藏
页码：S535 / S535
页数：1
相关论文
共 50 条
  • [1] Helicobacter pylori eradication rate of levofloxacin-based therapy
    Koo, Jiyeon
    Lee, Sihyung
    Kang, Minkyu
    Kim, Mincheol
    Park, Byungsam
    Jang, Byungik
    Kim, Taenyun
    [J]. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2018, 33 : 354 - 354
  • [2] Helicobacter pylori eradication with either quadruple regimen with lactoferrin or levofloxacin-based triple therapy:: A multicentre study
    Zullo, A.
    De Francesco, V.
    Scaccianoce, G.
    Manes, G.
    Efrati, C.
    Hassan, C.
    Maconi, G.
    Pighonica, D.
    Cannaviello, C.
    Panella, C.
    Morini, S.
    Lerardi, E.
    [J]. DIGESTIVE AND LIVER DISEASE, 2007, 39 (09) : 806 - 810
  • [3] ARE QUADRUPLE LEVOFLOXACIN-BASED REGIMENS AN EFFECTIVE ALTERNATIVE TO STANDARD SEQUENTIAL THERAPY IN THE ERADICATION OF HELICOBACTER PYLORI?
    Branquinho, D.
    Almeida, N.
    Fernandes, A.
    Casela, A.
    Pina Cabral, J.
    Gregorio, C.
    Donato, M.
    Calhau, C.
    Romaozinho, J.
    Sofia, C.
    [J]. HELICOBACTER, 2015, 20 : 95 - 95
  • [4] Efficacy of rabeprazole/levofloxacin-based triple therapy for Helicobacter pylori eradication
    Cammarota, G
    Cianci, R
    Vero, V
    Urgesi, R
    Gasbarrini, G
    [J]. GUT, 2002, 51 : A95 - A95
  • [5] ONCE-DAILY DOSE DEXLANSOPRAZOLE-LEVOFLOXACIN-BASED QUADRUPLE THERAPY FOR HELICOBACTER PYLORI ERADICATION: A RANDOMIZED CONTROLLED STUDY
    Siriwat, Parin
    Pulsombat, Akharawit
    [J]. GASTROENTEROLOGY, 2018, 154 (06) : S929 - S929
  • [6] A third-line levofloxacin-based rescue therapy for Helicobacter pylori eradication
    Zullo, A
    Hassan, C
    De Francesco, V
    Lorenzetti, R
    Marignani, M
    Angeletti, S
    Ierardi, E
    Morini, S
    [J]. DIGESTIVE AND LIVER DISEASE, 2003, 35 (04) : 232 - 236
  • [7] Helicobacter pylori eradication rate of levofloxacin-based therapy as third-line therapy
    Kang, M.
    Lee, S.
    Goo, E.
    Kim, K.
    Jang, B.
    Yang, C.
    [J]. HELICOBACTER, 2017, 22
  • [8] Efficacy of levofloxacin-based third-line therapy for the eradication of Helicobacter pylori in Seoul
    Lee, D.
    [J]. HELICOBACTER, 2019, 24
  • [9] Clinical trial:: levofloxacin-based quadruple therapy was inferior to traditional quadruple therapy in the treatment of resistant Helicobacter pylori infection
    Yee, Y. K.
    Cheung, T. K.
    Chu, K.-M.
    Chan, C. K.
    Fung, J.
    Chan, P.
    But, D.
    Hung, I.
    Chan, A. O. O.
    Yuen, M. F.
    Hsu, A.
    Wong, B. C. Y.
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2007, 26 (07) : 1063 - 1067
  • [10] Levofloxacin-based triple therapy in first-line treatment for Helicobacter pylori eradication
    Nista, Enrico C.
    Candelli, Marcello
    Zocco, Maria A.
    Cremonini, Filippo
    Ojetti, Veronica
    Finizio, Rosalba
    Spada, Cristiano
    Cammarota, Giovanni
    Gasbarrini, Giovanni
    Gasbarrini, Antonio
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2006, 101 (09): : 1985 - 1990
12345